Publications Database

Autism Research Institute (1990)

Dimethylglycine (DMG), a nontoxic metabolite, and autism.

Autism Research Review International

4(2), p. 3

Barrett S. (2000)

Orthomolecular therapy.

Quackwatch

Read Full (New Window)

Barthélémy C. et al. (1981)

Behavioral and biological effects of oral magnesium, vitamin B6, and combined magnesium-B6 administration in autistic children.

Magnesium Bulletin

2 pp. 150-153

Bashir S. , Al-Ayadhi L. Y. (2014)

Effect of camel milk on thymus and activation-regulated chemokine (TARC) in autistic children: double blind study.

Pediatric Research

April, 75(4), pp. 559-556.

Read Abstract (New Window)

Bazian (2011)

Supplements: Who needs them. A Behind the Headlines report.

London: Bazian

Read Full (New Window)

Bell J. et al. (2004)

Essential fatty acids and phospholipase A2 in autistic spectrum disorders.

Prostaglandins, Leukotrienes and Essential Fatty Acids

71(4), 201-4

Read Abstract (New Window)

Bender D. A. (2011)

Vitamin B6: Beyond adequacy

Journal of Evidence-Based Complementary and Alternative Medicine

16 pp. 29-39

Read Abstract (New Window)

Bent S. et al. (2011)

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder.

Journal of Autism and Developmental Disorders

41(5), pp. 545-554.

Read Abstract (New Window) Read Full (New Window)

Bent S. et al. (2014)

Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.

Journal of the American Academy of Child and Adolescent Psychiatry

June, 53(6), pp. 658-666.

Read Abstract (New Window)

Bent S. , Bertoglio K. , Hendren. R. L. (2009)

Omega-3 fatty acids for autistic spectrum disorder: A systematic review.

Journal of Autism and Developmental Disorders

39(8), pp. 1145-1154

Read Abstract (New Window) Read Full (New Window)

Bent S. , Bertoglio K. , Hendren. R. L. (2009)

Regarding omega-3 fatty acids in severe autism.

Archives of Medical Research

40(1), pp. 64

Berry R. C. et al. (2015)

Nutrition management of gastrointestinal symptoms in children with autism spectrum disorder: Guideline from an expert panel.

Journal of the Academy of Nutrition and Dietetics

December, 115(12), pp.1919-1927.

Read Abstract (New Window)

Bertoglio K. et al. (2010)

Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism.

Journal of Alternative and Complementary Medicine

May, 16(5), pp. 555-560

Read Abstract (New Window)

Bolman W. M. , Richmond J. (1999)

A double-blind, placebo-controlled crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.

Journal of Autism and Developmental Disorders

29(3), pp. 191-194

Read Abstract (New Window)

Boone K. M. et al. (2017)

Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial.

Early Human Development

December, 115 pp. 64-70.

Read Abstract (New Window)

Boyd C. , Moodambail A. (2016)

Severe hypercalcaemia in a child secondary to use of alternative therapies

BMJ Case Reports

Read Abstract (New Window)

Bradstreet J. J. , Vogelaar E. , Thyer L. (2014)

Initial observations of elevated alpha-n-acetylgalactosaminidase activity associated with autism and observed reductions from gc protein: Macrophage activating factor injections.

Autism Insights

Read Abstract (New Window) Read Full (New Window)

British Dietetic Association (2017)

Omega-3

London: British Dietetic Association

Read Full (New Window)

British Dietetic Association (2016)

Vitamin D.

London:

Read Full (New Window)

Brondino N. et al. (2015)

Complementary and alternative therapies for autism spectrum disorder.

Evidence Based Complementary and Alternative Medicine

Read Abstract (New Window) Read Full (New Window)